vs

Side-by-side financial comparison of Inogen Inc (INGN) and Youlife Group Inc. (YOUL). Click either name above to swap in a different company.

Youlife Group Inc. is the larger business by last-quarter revenue ($127.5M vs $68.6M, roughly 1.9× Inogen Inc).

Inogen Inc is a medical technology firm specializing in the development, production and distribution of portable oxygen concentrators and associated respiratory care products. It caters primarily to patients with chronic respiratory conditions needing long-term oxygen therapy across North America, Europe and other global markets, focusing on home care and ambulatory patient segments to enhance users' quality of life.

INGN vs YOUL — Head-to-Head

Bigger by revenue
YOUL
YOUL
1.9× larger
YOUL
$127.5M
$68.6M
INGN

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
INGN
INGN
YOUL
YOUL
Revenue
$68.6M
$127.5M
Net Profit
$5.2M
Gross Margin
51.4%
14.1%
Operating Margin
-13.6%
5.0%
Net Margin
4.1%
Revenue YoY
3.4%
Net Profit YoY
EPS (diluted)
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INGN
INGN
YOUL
YOUL
Q4 25
$68.6M
Q3 25
$79.1M
Q2 25
$79.2M
$127.5M
Q1 25
$68.5M
Q4 24
$66.3M
Q3 24
$74.9M
Q2 24
$74.4M
Q1 24
$63.1M
Net Profit
INGN
INGN
YOUL
YOUL
Q4 25
Q3 25
$-5.3M
Q2 25
$-4.2M
$5.2M
Q1 25
$-6.2M
Q4 24
Q3 24
$-6.0M
Q2 24
$-5.6M
Q1 24
$-14.6M
Gross Margin
INGN
INGN
YOUL
YOUL
Q4 25
51.4%
Q3 25
52.2%
Q2 25
52.2%
14.1%
Q1 25
53.1%
Q4 24
54.7%
Q3 24
55.2%
Q2 24
57.4%
Q1 24
54.5%
Operating Margin
INGN
INGN
YOUL
YOUL
Q4 25
-13.6%
Q3 25
-9.0%
Q2 25
-7.7%
5.0%
Q1 25
-11.2%
Q4 24
-17.2%
Q3 24
-10.4%
Q2 24
-9.5%
Q1 24
-25.8%
Net Margin
INGN
INGN
YOUL
YOUL
Q4 25
Q3 25
-6.7%
Q2 25
-5.2%
4.1%
Q1 25
-9.0%
Q4 24
Q3 24
-8.0%
Q2 24
-7.5%
Q1 24
-23.1%
EPS (diluted)
INGN
INGN
YOUL
YOUL
Q4 25
$-0.26
Q3 25
$-0.20
Q2 25
$-0.15
Q1 25
$-0.25
Q4 24
$-0.41
Q3 24
$-0.25
Q2 24
$-0.24
Q1 24
$-0.62

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INGN
INGN
YOUL
YOUL
Cash + ST InvestmentsLiquidity on hand
$103.7M
$22.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$192.2M
$-55.7M
Total Assets
$298.6M
$148.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INGN
INGN
YOUL
YOUL
Q4 25
$103.7M
Q3 25
$106.5M
Q2 25
$103.7M
$22.2M
Q1 25
$118.9M
Q4 24
$113.8M
Q3 24
$105.7M
Q2 24
$97.9M
Q1 24
$107.4M
Stockholders' Equity
INGN
INGN
YOUL
YOUL
Q4 25
$192.2M
Q3 25
$197.2M
Q2 25
$199.5M
$-55.7M
Q1 25
$198.0M
Q4 24
$173.9M
Q3 24
$185.4M
Q2 24
$187.6M
Q1 24
$191.9M
Total Assets
INGN
INGN
YOUL
YOUL
Q4 25
$298.6M
Q3 25
$307.0M
Q2 25
$312.0M
$148.8M
Q1 25
$308.4M
Q4 24
$296.2M
Q3 24
$306.2M
Q2 24
$308.9M
Q1 24
$315.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INGN
INGN
YOUL
YOUL
Operating Cash FlowLast quarter
$-943.0K
Free Cash FlowOCF − Capex
$-1.9M
FCF MarginFCF / Revenue
-2.8%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-13.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INGN
INGN
YOUL
YOUL
Q4 25
$-943.0K
Q3 25
$2.2M
Q2 25
$4.3M
Q1 25
$-16.8M
Q4 24
$-3.0M
Q3 24
$7.0M
Q2 24
$6.7M
Q1 24
$-4.7M
Free Cash Flow
INGN
INGN
YOUL
YOUL
Q4 25
$-1.9M
Q3 25
$1.6M
Q2 25
$3.7M
Q1 25
$-17.1M
Q4 24
$-3.3M
Q3 24
$5.3M
Q2 24
$6.6M
Q1 24
$-6.1M
FCF Margin
INGN
INGN
YOUL
YOUL
Q4 25
-2.8%
Q3 25
2.0%
Q2 25
4.6%
Q1 25
-24.9%
Q4 24
-5.0%
Q3 24
7.1%
Q2 24
8.9%
Q1 24
-9.6%
Capex Intensity
INGN
INGN
YOUL
YOUL
Q4 25
1.4%
Q3 25
0.7%
Q2 25
0.9%
Q1 25
0.4%
Q4 24
0.5%
Q3 24
2.2%
Q2 24
0.1%
Q1 24
2.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

INGN
INGN

Other$36.1M53%
Non Us$32.5M47%

YOUL
YOUL

Segment breakdown not available.

Related Comparisons